FDA Inspection 892573 — Ipsen BioPharm Ltd

Ipsen BioPharm Ltd — FEI 1000346340

The FDA completed an inspection of Ipsen BioPharm Ltd on Jul 8, 2014 in Wrexham. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 8, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Wrexham (United Kingdom)

Citations

IDCFRDescription
457621 CFR 211.192No written record of investigation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.